Related Experiment Video
Updated: Sep 4, 2025
06:39
Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity
Published on: September 1, 2023
3.0K
Bacterial membrane vesicles in inflammatory bowel disease
Qichen Shen1, Bingbai Xu2, Caihong Wang1
1Department of Biotechnology, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China.
Life Sciences
|July 19, 2022
Summary
Bacterial membrane vesicles (MVs) are key to gut health and communication. This review explores their role in inflammatory bowel disease (IBD) and their therapeutic potential for IBD patients.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Inflammatory bowel disease (IBD) involves chronic intestinal inflammation with no known cure.
- Disruption of the gut microbial ecosystem is a significant factor contributing to IBD development.
- Host-microbiota interactions critically influence intestinal barrier function and immune responses.
Purpose of the Study:
- To review current knowledge on bacterial membrane vesicles (MVs).
- To specifically focus on the roles of gut bacterial MVs in inflammatory bowel disease (IBD).
- To summarize the therapeutic potential of MVs for IBD treatment.
Main Methods:
- Literature review of current research on bacterial membrane vesicles.
- Analysis of studies investigating the impact of gut bacterial MVs on intestinal microecology.
- Evaluation of the potential of MVs as a therapeutic strategy for IBD.
Main Results:
- Bacterial MVs are crucial mediators of inter-bacterial and host-microbiota communication.
- MVs demonstrate significant regulatory effects on intestinal microecology.
- Gut bacterial MVs play a notable role in the pathogenesis and progression of IBD.
Conclusions:
- Bacterial MVs hold considerable promise for novel therapeutic applications in IBD.
- Understanding MV functions offers new avenues for managing intestinal inflammation.
- MVs represent a potential innovative treatment strategy for patients with inflammatory bowel disease.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
367
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
367
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
304
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
304
01:29Inflammatory Bowel Disease IV: Pharmacological Management
176
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
176
01:17Chronic Bowel Disorders: Introduction
534
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
534
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
226
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
226
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
402
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
402